| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/DKU164 |
| P8608 | Fatcat ID | release_g6onz43tavbhxhbfa7hvqymg74 |
| P698 | PubMed publication ID | 24894419 |
| P5875 | ResearchGate publication ID | 262845721 |
| P50 | author | Shin Ito | Q55221631 |
| P2093 | author name string | Takashi Deguchi | |
| Takayuki Ezaki | |||
| Mitsuru Yasuda | |||
| Tomohiro Tsuchiya | |||
| Mina Kikuchi | |||
| Kyoko Hatazaki | |||
| Masaki Takanashi | |||
| P2860 | cites work | Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic | Q21133562 |
| The Minimal Gene Complement of Mycoplasma genitalium | Q22065573 | ||
| Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis | Q24605678 | ||
| Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system | Q33355815 | ||
| Persistence of Mycoplasma genitalium following azithromycin therapy | Q33382111 | ||
| Macrolide resistance conferred by base substitutions in 23S rRNA. | Q34106180 | ||
| Sequence-based typing of Mycoplasma genitalium reveals sexual transmission | Q34719702 | ||
| Rapid Detection of Mycoplasma genitalium , Mycoplasma hominis , Ureaplasma parvum , and Ureaplasma urealyticum Organisms in Genitourinary Samples by PCR-Microtiter Plate Hybridization Assay | Q34990476 | ||
| Mycoplasma genitalium: from Chrysalis to multicolored butterfly | Q35090137 | ||
| Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen | Q35635718 | ||
| Azithromycin failure in Mycoplasma genitalium urethritis | Q35792616 | ||
| Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium | Q36971250 | ||
| Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium | Q37191589 | ||
| High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. | Q37579937 | ||
| Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis | Q37713726 | ||
| Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis | Q37846420 | ||
| Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin | Q37849266 | ||
| Method comparison for molecular typing of French and Tunisian Mycoplasma genitalium-positive specimens. | Q37849678 | ||
| Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis | Q37851728 | ||
| Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis | Q38040151 | ||
| Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli | Q39816339 | ||
| Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. | Q42111508 | ||
| Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance | Q43004634 | ||
| Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance | Q43722862 | ||
| Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment | Q43778996 | ||
| Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance | Q46260038 | ||
| Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study | Q46340504 | ||
| Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. | Q54359754 | ||
| Mechanism of action of and resistance to quinolones | Q58057075 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Japan | Q17 |
| Mycoplasma genitalium | Q1930909 | ||
| P304 | page(s) | 2376-2382 | |
| P577 | publication date | 2014-06-02 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan | |
| P478 | volume | 69 |
| Q38922868 | 2016 European guideline on Mycoplasma genitalium infections |
| Q36933110 | A 5' Nuclease Genotyping Assay for Identification of Macrolide-Resistant Mycoplasma genitalium in Clinical Specimens. |
| Q37280597 | A Novel SimpleProbe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples. |
| Q38772340 | Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium |
| Q38949023 | Background review for the 2016 European guideline on Mycoplasma genitalium infections |
| Q21284727 | Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health |
| Q38609853 | Developing a Public Health Response to Mycoplasma genitalium |
| Q26744660 | Drug Resistance Mechanisms in Bacteria Causing Sexually Transmitted Diseases and Associated with Vaginosis |
| Q35673469 | Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan |
| Q38646438 | Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections |
| Q42339724 | Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France |
| Q93077104 | Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection |
| Q33597030 | Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium |
| Q93157101 | Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis |
| Q57035503 | Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis |
| Q60937233 | Looking at the positives: proactive management of STIs in people with HIV |
| Q48537471 | Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015. |
| Q64239107 | Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014 |
| Q37837623 | Male non-gonococcal urethritis: From microbiological etiologies to demographic and clinical features |
| Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
| Q92755899 | Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium |
| Q53812158 | Multidrug-Resistant Mycoplasma genitalium Is Increasing. |
| Q40271087 | Multidrug-resistant Mycoplasma genitalium infections in Europe |
| Q55234408 | Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. |
| Q92798143 | Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand |
| Q89444103 | Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama |
| Q94450769 | Mycoplasma genitalium in Singapore is associated with Chlamydia trachomatis infection and displays high macrolide and Fluoroquinolone resistance rates |
| Q27021073 | Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations |
| Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
| Q40063952 | Mycoplasma genitalium macrolide and fluoroquinolone resistance detection and clinical implications in a selected cohort in New Zealand |
| Q90111635 | Mycoplasma genitalium, a stealth female reproductive tract |
| Q40071934 | Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment |
| Q38903015 | Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections |
| Q38609857 | New Horizons in Mycoplasma genitalium Treatment |
| Q62896269 | Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation |
| Q33562762 | Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia |
| Q97075329 | Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis |
| Q50112578 | Proposed treatment strategies for non-gonococcal urethritis |
| Q38560388 | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis |
| Q64098896 | Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against Species Clinical Isolates and Type Strains |
| Q49755869 | Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection |
Search more.